However, to fully assess its specificity, future studies should investigate whether C1qtnf6 expression is also elevated in nonmalignant lung diseases, such as COPD or pulmonary fibrosis, to determine its potential diagnostic boundaries. Here, C1QTNF6 is linked to chronic obstructive pulmonary disease.